ES2113985T3 - Material de recubrimiento para formas medicamentosas de administracion oral. - Google Patents

Material de recubrimiento para formas medicamentosas de administracion oral.

Info

Publication number
ES2113985T3
ES2113985T3 ES93116525T ES93116525T ES2113985T3 ES 2113985 T3 ES2113985 T3 ES 2113985T3 ES 93116525 T ES93116525 T ES 93116525T ES 93116525 T ES93116525 T ES 93116525T ES 2113985 T3 ES2113985 T3 ES 2113985T3
Authority
ES
Spain
Prior art keywords
coating material
oral administration
drug forms
active substance
envelops
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93116525T
Other languages
English (en)
Inventor
Verena Siefke
Ullrich Dr Hanstein
Hans Peter Dr Weckenmann
Kurt Prof Dr Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2113985T3 publication Critical patent/ES2113985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UNA FORMA DE MEDICAMENTO ORAL, CONTENIENDO AL MENOS UNA SUSTANCIA ACTIVA Y AL MENOS UN MATERIAL DE ENVOLTURA O RECUBRIMIENTO QUE RODEA LA SUSTANCIA ACTIVA, QUE CONTIENE AL MENOS UN FORMADOR DE PELICULA INSOLUBLE EN AGUA Y EN LOS ACIDOS DIGESTIVOS, CARACTERIZADO PORQUE, EL MATERIAL DE ENVOLTURA CONTIENE AL MENOS ADICIONALMENTE UNA CICLODEXTRINA Y/O AL MENOS UNO DE SUS DERIVADOS.
ES93116525T 1992-10-24 1993-10-13 Material de recubrimiento para formas medicamentosas de administracion oral. Expired - Lifetime ES2113985T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4236025A DE4236025A1 (de) 1992-10-24 1992-10-24 Orale Arzneiformen

Publications (1)

Publication Number Publication Date
ES2113985T3 true ES2113985T3 (es) 1998-05-16

Family

ID=6471319

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93116525T Expired - Lifetime ES2113985T3 (es) 1992-10-24 1993-10-13 Material de recubrimiento para formas medicamentosas de administracion oral.

Country Status (21)

Country Link
EP (1) EP0595110B1 (es)
JP (1) JPH06199702A (es)
KR (1) KR100263793B1 (es)
CN (1) CN1055617C (es)
AT (1) ATE161715T1 (es)
AU (1) AU668767B2 (es)
CA (1) CA2109026A1 (es)
CZ (1) CZ283498B6 (es)
DE (2) DE4236025A1 (es)
DK (1) DK0595110T3 (es)
ES (1) ES2113985T3 (es)
GR (1) GR3026504T3 (es)
HU (1) HU218670B (es)
MX (1) MX9306564A (es)
NO (1) NO306975B1 (es)
PL (1) PL173370B1 (es)
RU (1) RU2116785C1 (es)
SK (1) SK279774B6 (es)
TW (1) TW263439B (es)
UA (1) UA27239C2 (es)
ZA (1) ZA937876B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
DK1104291T3 (da) * 1998-07-17 2006-01-16 Janssen Pharmaceutica Nv Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
RU2147878C1 (ru) * 1999-08-12 2000-04-27 Открытое акционерное общество Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая энтеральным действием
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
CA2559239C (en) * 2004-04-13 2021-04-06 Boehringer Ingelheim International Gmbh Use of simethicone and sodium picosulphate in constipated patients suffering from bloated feeling and gas discomfort during the night
TWI345405B (en) 2007-12-26 2011-07-11 Ind Tech Res Inst Apparatus and method for executing the handoff process in wireless networks
CN101919803A (zh) * 2010-07-16 2010-12-22 钟术光 一种控释制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129138A (ja) * 1984-11-16 1986-06-17 Takeda Chem Ind Ltd 被覆製剤
ES2095894T3 (es) 1990-10-18 1997-03-01 Basf Ag Derivados de galactomanano para el revestimiento o la incrustacion de productos activos farmaceuticos.
DE9015551U1 (de) 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid

Also Published As

Publication number Publication date
DE59307930D1 (de) 1998-02-12
SK279774B6 (sk) 1999-03-12
TW263439B (es) 1995-11-21
DE4236025A1 (de) 1994-04-28
KR100263793B1 (ko) 2000-09-01
NO933803L (no) 1994-04-25
CZ222293A3 (en) 1994-05-18
MX9306564A (es) 1994-06-30
RU2116785C1 (ru) 1998-08-10
ZA937876B (en) 1994-05-24
JPH06199702A (ja) 1994-07-19
SK116393A3 (en) 1994-05-11
CN1090171A (zh) 1994-08-03
AU4914893A (en) 1994-05-05
CA2109026A1 (en) 1994-04-25
HU9303006D0 (en) 1994-01-28
CZ283498B6 (cs) 1998-04-15
KR940008674A (ko) 1994-05-16
EP0595110A1 (de) 1994-05-04
GR3026504T3 (en) 1998-07-31
HUT67167A (en) 1995-02-28
CN1055617C (zh) 2000-08-23
AU668767B2 (en) 1996-05-16
ATE161715T1 (de) 1998-01-15
UA27239C2 (uk) 2000-08-15
EP0595110B1 (de) 1998-01-07
PL173370B1 (pl) 1998-02-27
HU218670B (hu) 2000-10-28
NO933803D0 (no) 1993-10-22
DK0595110T3 (da) 1998-09-07
NO306975B1 (no) 2000-01-24

Similar Documents

Publication Publication Date Title
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
DE69104724D1 (de) Florfenicol enthaltendes arzneimittel.
BR9100843A (pt) Inalador e embalagem de medicamento para aplicacao com o mesmo
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
AU668767B2 (en) Oral medicament form
ES2141117T3 (es) Agentes farmaceuticos con sabor enmascarado.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
ATE271387T1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
RU93048335A (ru) Оральная лекарственная форма, материал для оболочки
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
AR033862A1 (es) Formulacion de medicamento que contiene un agente agonista muscarinico
KR930000109A (ko) 참. 존
ATE4713T1 (de) 2-oxo-benzothiazolin-, benzoxazolin- oder indolin-derivate, deren herstellung und derartige verbindungen enthaltende pharmazeutische zusammensetzungen.
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene
SK131U (sk) Nosná hmlotvorná kvapalina pre aplikáciu biologicky aktívnych látok formou hmly.
ITRM940505A0 (it) "agente attivo per il trattamento di infezioni croniche da immunodepressione e per contrastare lo sviluppo di tumori favoriti da immunodepressione".
FR2698790B1 (fr) Compositions pharmaceutiques contenant du diltiazem et de la molsidomine.
ATE37539T1 (de) Imidazol-derivate und salze, deren herstellung und pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595110

Country of ref document: ES